To determine whether PD-1 was blocking T cells that might have otherwise expressed IFNγ, we treated mice containing or lacking NK cells with anti-PD-1 starting on D3 after tumor implantation and harvested on D7. The gene discussed is IFNG; the disease is neoplasm.